200 related articles for article (PubMed ID: 34677571)
1. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study.
Jaakkola J; Teppo K; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Aro AL; Hartikainen J; Airaksinen KEJ; Lehto M
Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):269-276. PubMed ID: 34677571
[TBL] [Abstract][Full Text] [Related]
2. Mental Health Conditions and Nonpersistence of Direct Oral Anticoagulant Use in Patients With Incident Atrial Fibrillation: A Nationwide Cohort Study.
Teppo K; Jaakkola J; Airaksinen KEJ; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Hartikainen J; Luojus A; Niemi M; Linna M; Lehto M
J Am Heart Assoc; 2022 Mar; 11(6):e024119. PubMed ID: 35229612
[TBL] [Abstract][Full Text] [Related]
3. Mental health conditions and risk of first-ever ischaemic stroke and death in patients with incident atrial fibrillation: A nationwide cohort study.
Teppo K; Jaakkola J; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Kouki E; Penttilä T; Hartikainen J; Aro AL; Airaksinen KEJ; Lehto M
Eur J Clin Invest; 2022 Sep; 52(9):e13801. PubMed ID: 35484936
[TBL] [Abstract][Full Text] [Related]
4. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
Højen AA; Nielsen PB; Riahi S; Jensen M; Lip GYH; Larsen TB; Søgaard M
Br J Clin Pharmacol; 2022 Aug; 88(8):3847-3855. PubMed ID: 35355307
[TBL] [Abstract][Full Text] [Related]
5. Mental health conditions and adherence to direct oral anticoagulants in patients with incident atrial fibrillation: A nationwide cohort study.
Teppo K; Jaakkola J; Airaksinen KEJ; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Hartikainen J; Luojus A; Niemi M; Linna M; Lehto M
Gen Hosp Psychiatry; 2022; 74():88-93. PubMed ID: 34999528
[TBL] [Abstract][Full Text] [Related]
6. Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation.
Teppo K; Airaksinen KEJ; Jaakkola J; Halminen O; Salmela B; Kalatsova K; Kouki E; Haukka J; Putaala J; Linna M; Aro AL; Mustonen P; Hartikainen J; Lehto M
Eur J Clin Invest; 2024 Jan; 54(1):e14107. PubMed ID: 37823410
[TBL] [Abstract][Full Text] [Related]
7. Mental health conditions and use of rhythm control therapies in patients with atrial fibrillation: a nationwide cohort study.
Teppo K; Jaakkola J; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Luojus A; Itäinen-Strömberg S; Penttilä T; Niemi M; Hartikainen J; Airaksinen KJ; Lehto M
BMJ Open; 2022 Aug; 12(8):e059759. PubMed ID: 36041755
[TBL] [Abstract][Full Text] [Related]
8. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
[TBL] [Abstract][Full Text] [Related]
9. Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
Teppo K; Jaakkola J; Langén VL; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Hartikainen J; Airaksinen KEJ; Lehto M
PLoS One; 2022; 17(10):e0276612. PubMed ID: 36315505
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016.
Maura G; Billionnet C; Drouin J; Weill A; Neumann A; Pariente A
BMJ Open; 2019 Apr; 9(4):e026645. PubMed ID: 31005934
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
12. Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
Gadsbøll K; Staerk L; Fosbøl EL; Sindet-Pedersen C; Gundlund A; Lip GYH; Gislason GH; Olesen JB
Eur Heart J; 2017 Mar; 38(12):899-906. PubMed ID: 28110293
[TBL] [Abstract][Full Text] [Related]
13. Mental health conditions and bleeding events in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Putaala J; Mustonen P; Kinnunen J; Jolkkonen S; Niemi M; Hartikainen J; Airaksinen KEJ; Lehto M
Gen Hosp Psychiatry; 2022; 78():117-122. PubMed ID: 36057233
[TBL] [Abstract][Full Text] [Related]
14. Contemporary management of atrial fibrillation in primary and secondary care in the UK: the prospective long-term AF-GEN-UK Registry.
Shantsila A; Lip GYH; Lane DA
Europace; 2023 Feb; 25(2):308-317. PubMed ID: 36037021
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre Berlin Atrial Fibrillation Registry.
Haeusler KG; Tütüncü S; Kunze C; Schurig J; Malsch C; Harder J; Wiedmann S; Dimitrijeski B; Ebinger M; Hagemann G; Hamilton F; Honermann M; Jungehulsing GJ; Kauert A; Koennecke HC; Leithner C; Mackert BM; Masuhr F; Nabavi D; Rocco A; Schmehl I; Schmitz B; Sparenberg P; Stingele R; von Brevern M; Völzke E; Dietzel J; Heuschmann PU; Endres M
Europace; 2019 Nov; 21(11):1621-1632. PubMed ID: 31397475
[TBL] [Abstract][Full Text] [Related]
16. Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
Bayer V; Kotalczyk A; Kea B; Teutsch C; Larsen P; Button D; Huisman MV; Lip GYH; Olshansky B
J Am Heart Assoc; 2022 Mar; 11(6):e023907. PubMed ID: 35243870
[TBL] [Abstract][Full Text] [Related]
17. Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation.
Fenger-Grøn M; Vestergaard CH; Ribe AR; Johnsen SP; Frost L; Sandbæk A; Davydow DS
JAMA Netw Open; 2021 May; 4(5):e2110096. PubMed ID: 33999163
[TBL] [Abstract][Full Text] [Related]
18. Oral Anticoagulant Therapy and Risk of Admission to Long-Term Care in patients With Atrial Fibrillation: A Nationwide Cohort Study.
Teppo K; Airaksinen KEJ; Halminen O; Linna M; Jaakkola J; Haukka J; Putaala J; Mustonen P; Langén VL; Kinnunen J; Hartikainen J; Lehto M
J Am Med Dir Assoc; 2023 Oct; 24(10):1484-1489. PubMed ID: 37348842
[TBL] [Abstract][Full Text] [Related]
19. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020.
Ko D; Lin KJ; Bessette LG; Lee SB; Walkey AJ; Cheng S; Kim E; Glynn RJ; Kim DH
JAMA Netw Open; 2022 Nov; 5(11):e2242964. PubMed ID: 36399339
[TBL] [Abstract][Full Text] [Related]
20. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
